These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 32342546
21. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q. Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [Abstract] [Full Text] [Related]
22. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225 [Abstract] [Full Text] [Related]
23. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer. Campos LC, Silva JO, Santos FS, Araújo MR, Lavalle GE, Ferreira E, Cassali GD. J Vet Diagn Invest; 2015 Jul 15; 27(4):531-5. PubMed ID: 26179096 [Abstract] [Full Text] [Related]
24. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer. McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ. BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182 [Abstract] [Full Text] [Related]
25. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma. Zhang Y, Pan J, Xu D, Yang Z, Sun J, Sun L, Wu Y, Qiao H. Oncol Rep; 2018 Dec 10; 40(6):3611-3624. PubMed ID: 30542708 [Abstract] [Full Text] [Related]
26. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors. Ramadan ES, Salem NY, Emam IA, AbdElKader NA, Farghali HA, Khattab MS. Vet Res Commun; 2022 Jun 10; 46(2):377-388. PubMed ID: 34787777 [Abstract] [Full Text] [Related]
27. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Zuccari DA, Santana AE, Cury PM, Cordeiro JA. Vet Clin Pathol; 2004 Jun 10; 33(1):23-8. PubMed ID: 15048623 [Abstract] [Full Text] [Related]
28. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W, Miao Y. Cancer Med; 2019 Jun 10; 8(6):2810-2822. PubMed ID: 31006985 [Abstract] [Full Text] [Related]
29. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease. Cirera S, Andersen-Ranberg EU, Langkilde S, Aaquist M, Gredal H. Acta Vet Scand; 2019 Dec 03; 61(1):57. PubMed ID: 31796072 [Abstract] [Full Text] [Related]
30. miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma. Karttunen J, Kalmar L, Grant A, Ying J, Stewart SE, Wang X, Frankl FK, Williams T. Sci Rep; 2024 Aug 02; 14(1):17967. PubMed ID: 39095540 [Abstract] [Full Text] [Related]
31. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma. Heinemann FG, Tolkach Y, Deng M, Schmidt D, Perner S, Kristiansen G, Müller SC, Ellinger J. Clin Epigenetics; 2018 Aug 02; 10():11. PubMed ID: 29410711 [Abstract] [Full Text] [Related]
32. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours. Bulkowska M, Rybicka A, Senses KM, Ulewicz K, Witt K, Szymanska J, Taciak B, Klopfleisch R, Hellmén E, Dolka I, Gure AO, Mucha J, Mikow M, Gizinski S, Krol M. BMC Cancer; 2017 Nov 07; 17(1):728. PubMed ID: 29115935 [Abstract] [Full Text] [Related]
33. YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors. Hasan MN, Rahman MM, Husna AA, Nozaki N, Yamato O, Miura N. Biochem Biophys Res Commun; 2024 Jan 08; 691():149336. PubMed ID: 38039834 [Abstract] [Full Text] [Related]
34. Influence of host factors on survival in dogs with malignant mammary gland tumors. Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ. J Vet Intern Med; 2003 Jan 08; 17(1):102-6. PubMed ID: 12564734 [Abstract] [Full Text] [Related]
35. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer. Peng W, Liu YN, Zhu SQ, Li WQ, Guo FC. Cancer Med; 2018 Aug 08; 7(8):3773-3791. PubMed ID: 30003708 [Abstract] [Full Text] [Related]
36. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H, Ghanadian S, Pakravan K, Razmara E, Rouhollah F, Mossahebi-Mohammadi M, Babashah S. Life Sci; 2020 Oct 01; 258():118226. PubMed ID: 32771555 [Abstract] [Full Text] [Related]
37. Ceramide galactosyltransferase (UGT8) as a molecular marker of canine mammary tumor malignancy. Nowak M, Dziegiel P, Madej J, Ugorski M. Folia Histochem Cytobiol; 2013 Oct 01; 51(2):164-7. PubMed ID: 23907947 [Abstract] [Full Text] [Related]
38. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems. Pereira PD, Lopes CC, Matos AJ, Cortez PP, Gärtner F, Medeiros R, Lopes C. J Comp Pathol; 2010 Oct 01; 143(2-3):87-93. PubMed ID: 20153868 [Abstract] [Full Text] [Related]
39. Systematic analysis of different degrees of haemolysis on miRNA levels in serum and serum-derived extracellular vesicles from dogs. Aguilera-Rojas M, Sharbati S, Stein T, Candela Andrade M, Kohn B, Einspanier R. BMC Vet Res; 2022 Sep 22; 18(1):355. PubMed ID: 36138476 [Abstract] [Full Text] [Related]
40. Comparison of B-mode and Doppler ultrasonographic findings with histologic features of benign and malignant mammary tumors in dogs. Nyman HT, Nielsen OL, McEvoy FJ, Lee MH, Martinussen T, Hellmén E, Kristensen AT. Am J Vet Res; 2006 Jun 22; 67(6):985-91. PubMed ID: 16740091 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]